Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy

Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy

Cytokines regulate virtually aspects of innate and adaptive immunity, including the initiation, execution and extinction of tumor-targeting immune responses. Over the past three decades, the possibility of using recombinant cytokines as a means to elicit or boost clinically relevant anticancer immun...

Full description

Bibliographic Details
Main Authors: Elena García-Martínez, Melody Smith, Aitziber Buqué, Fernando Aranda, Francisco Ayala de la Peña, Alejandra Ivars, Manuel Sanchez Cánovas, Ma Angeles Vicente Conesa, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi
Format: Article
Language:English
Published: Taylor & Francis Group 2018-06-01
Series:OncoImmunology
Subjects:
car t cells
ctla4
gm-csf
il-15
pd-1
pembrolizumab
Online Access:http://dx.doi.org/10.1080/2162402X.2018.1433982

Internet

http://dx.doi.org/10.1080/2162402X.2018.1433982

Similar Items